NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis. Zhao Z, Zheng ZY, Lei JT, Baik MJ, et al. Cancer Lett 2026;655:218636.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao Z, Zheng ZY, Lei JT, Baik MJ, et al. NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis. Cancer Lett 2026;655:218636.
PMID: 42217562